CEP
AGN

Chicago Equity Partners’s Allergan plc AGN Stock Holding History

Chicago Equity Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$628K Sell
3,545
-930
-21% -$175K 0.06% 377
2019
Q4 		$855K Sell
4,475
-2,849
-39% -$514K 0.05% 505
2019
Q3 		$1.23M Buy
7,324
+1,349
+23% +$220K 0.06% 436
2019
Q2 		$1M Buy
5,975
+3,470
+139% +$480K 0.04% 519
2019
Q1 		$367K Sell
2,505
-150
-6% -$21.7K 0.01% 730
2018
Q4 		$355K Buy
+2,655
New +$435K 0.01% 695
2018
Q1 		– Sell
-70,795
Closed -$11.6M – 841
2017
Q4 		$11.6M Sell
70,795
-13,275
-16% -$2.38M 0.35% 67
2017
Q3 		$17.2M Buy
84,070
+31,835
+61% +$7.4M 0.54% 32
2017
Q2 		$12.7M Buy
52,235
+26,085
+100% +$6.13M 0.34% 73
2017
Q1 		$6.25M Buy
26,150
+24,625
+1,615% +$5.73M 0.18% 142
2016
Q4 		$320K Sell
1,525
-2,670
-64% -$553K 0.01% 655
2016
Q3 		$966K Sell
4,195
-1,010
-19% -$247K 0.03% 437
2016
Q2 		$1.2M Sell
5,205
-6,577
-56% -$1.52M 0.04% 366
2016
Q1 		$3.16M Sell
11,782
-2,610
-18% -$747K 0.09% 197
2015
Q4 		$4.5M Sell
14,392
-6,457
-31% -$1.92M 0.12% 164
2015
Q3 		$5.67M Buy
20,849
+915
+5% +$281K 0.16% 140
2015
Q2 		$6.05M Sell
19,934
-16,805
-46% -$5.01M 0.16% 138
2015
Q1 		$10.9M Buy
36,739
+9,720
+36% +$2.77M 0.29% 102
2014
Q4 		$6.96M Sell
27,019
-4,905
-15% -$1.23M 0.19% 130
2014
Q3 		$7.7M Sell
31,924
-58,916
-65% -$13.2M 0.2% 119
2014
Q2 		$20.3M Buy
90,840
+73,250
+416% +$15.2M 0.54% 69
2014
Q1 		$3.62M Buy
17,590
+4,165
+31% +$825K 0.1% 169
2013
Q4 		$2.25M Buy
13,425
+10,925
+437% +$1.71M 0.07% 204
2013
Q3 		$360K Sell
2,500
-10
-0.4% -$1.33K 0.01% 362
2013
Q2 		$316K Buy
+2,510
New +$284K 0.01% 372

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Chicago Equity Partners's AGN Position: Q1 2020 in Review

Chicago Equity Partners reduced its Allergan plc (AGN) stake by 21% in Q1 2020, selling an estimated $175K and leaving 3,545 shares worth $628K. The position accounts for 0.06% of the portfolio, ranked #377.

Chicago Equity Partners first reported a position in AGN in Q2 2013 and has held it in 25 quarters since. The position peaked at $20.3M in Q2 2014. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Chicago Equity Partners held 3,545 shares of Allergan plc worth $628K as of Q1 2020.
  • Chicago Equity Partners sold 930 Allergan plc shares in Q1 2020, an estimated $175K.
  • Allergan plc made up 0.06% of Chicago Equity Partners's portfolio in Q1 2020, its #377 holding.
  • Chicago Equity Partners first reported a position in Allergan plc in Q2 2013 and has held it in 25 quarters since.
  • Chicago Equity Partners's Allergan plc position peaked at $20.3M in Q2 2014.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.